Efficacy and safety of Rituximab in B-cell post transplantation lymphoproliferative disorders (B-PTLD): Preliminary results of a multicenter, open label, phase II trial (M39037 TRIAL)
暂无分享，去创建一个
G. Salles | É. Oksenhendler | A. Moreau | S. Choquet | P. Vandenberghe | Y. Lebranchu | G. Socié | R. Herbrecht | N. Milpied | F. Offner | A. Jaccard | A. Stoppa | P. Lang | A. Fischer | T. Lamy | E. Vilmer | F. Morschauser | Leblond | K. Imadalou | J. Garnier | S. Fafi | W. Feremens